Form 4: Merit Medical Systems Director Lynne Ward Reports Stock and Option Transactions

Director Lynne Ward reports acquisition of restricted stock units and holdings of stock options in Merit Medical Systems.

Summary

• On May 15, 2025, Lynne Ward, a director of Merit Medical Systems Inc., reported the acquisition of 2,152 shares of common stock through restricted stock units (RSUs) at a price of $0.
• These RSUs were granted under the company's 2018 Long-Term Incentive Plan and will vest on May 15, 2026, contingent upon continued service to the issuer.
• Following the transaction, Ward directly owns 12,809 shares of Merit Medical Systems Inc.
• Ward also holds non-qualified stock options for 5,433 shares of common stock with an exercise price of $34.46, granted on August 28, 2020, and exercisable in equal annual installments of 33%.

Sentiment

Score: 6

Explanation: The sentiment is neutral. It's a routine disclosure of stock transactions by a company director. The acquisition of RSUs is a positive sign, but it's not a major event.

Positives

• The acquisition of RSUs by a director signals confidence in the company's future performance.
• The vesting schedule tied to continued service aligns the director's interests with those of the shareholders.

Future Outlook

The vesting of the RSUs on May 15, 2026, is contingent upon continued service to the issuer.

Industry Context

Form 4 filings are routine disclosures required by the SEC to provide transparency regarding the transactions of company insiders. These filings are closely watched by investors as they can provide insights into management's views on the company's prospects.

Comparison to Industry Standards

• Stock option and RSU grants are a common form of compensation for directors and executives in publicly traded companies, including those in the medical device industry.
• Companies like Medtronic, Stryker, and Boston Scientific also utilize similar equity-based compensation plans to align management's interests with shareholder value.
• The vesting schedules and exercise prices are generally in line with industry practices.

Stakeholder Impact

• The transaction provides transparency to shareholders regarding the director's holdings and alignment with company performance.

Key Dates

Keywords

Form 4, Merit Medical Systems, MMSI, Director, Lynne Ward, Restricted Stock Units, Stock Options, Beneficial Ownership, Securities Exchange Act